Logo yposkesi
waves image

Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant gene therapy manufacturing capacity

In the framework of a preferred partnership, Yposkesi plans to grant Axovant access to dedicated cGMP capacity and manufacturing resources to further support the global development and commercialization of Axovant’s AAV-based gene therapy programs.

In the framework of a preferred partnership, Yposkesi plans to grant Axovant access to dedicated cGMP capacity and manufacturing resources to further support the global development and commercialization of Axovant’s AAV-based gene therapy programs.

Axovant YPK EN 181128

Axovant YPK_FR 181128